Peptide 22
Peptide 22 is a polypeptide that binds to EGFR. Peptide 22 competes with endogenous EGF for EGFR binding sites and is taken up by triple-negative breast cancer cells in a dose-dependent manner. Peptide 22 can be used in studies related to triple-negative breast cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3030200-17-7
- Fòrmula: C75H96N16O20
- Peso molecular:1541.66
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas EGFR
More
Actividad biológica
Peptide 22 (YHWYGYTPENVI) (2 μM) specifically binds to EGFR on MDA-MB-468 and MDA-MB-231 triple-negative breast cancer cells, with significantly higher uptake than the parent GE11 peptide and dose-dependent binding saturation at 2 μM in MDA-MB-231 cells[1].
Peptide 22 shows high uptake in MDA-MB-468 and MDA-MB-231 triple-negative breast cancer cells but has low serum stability, requiring cyclization to enhance in vivo utility[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 3030200-17-7
-
Peso molecular 1541.66
-
Fòrmula C75H96N16O20
-
SMILES
O=C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(N[C@@H](CC4=CC=C(C=C4)O)C(NCC(N[C@@H](CC5=CC=C(C=C5)O)C(N[C@@H]([C@H](O)C)C(N6[C@@H](CCC6)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC7=CC=C(C=C7)O)N
-
Sequence
Tyr-His-Trp-Tyr-Gly-Tyr-Thr-Pro-Glu-Asn-Val-Ile
-
Sequence Shortening
YHWYGYTPENVI
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)